Toggle Mobile Navigation

Cytel at the Adaptive Clinical Trials Symposium — Download Complimentary Cytel Whitepaper: Adaptive Trial Accelerates FDA Approval

An average clinical trial can cost $60–80 million. Adaptive design allows a sponsor to modify multiple parts of a trial without incurring additional costs. Using this innovative method will present the opportunity to stipulate collected data at various intervals in order to adjust one or more detailed aspects of the study based on analysis of the data. It is proven that this approach will allow a trial to more efficiently demonstrate the effects of a drug.

Take an in-depth look at how Cytel assisted Napo Pharmaceuticals to optimize an adaptive speed and control to achieve orphan drug exclusivity protection. This paper will explain the challenges Napo encountered in order to gain approval from the FDA for their drug Fulyzaq. For this instance, Cytel recommended an implementation of the Two-Stage Adaptive Confirmatory Design.

Click here to download the Adaptive Trial Accelerates FDA Approval whitepaper. We hope you find this paper valuable. To continue the conversation and learn more, join your industry peers in Philadelphia this March 22–23 for the Adaptive Clinical Trials Symposium.

Click here to reserve your seat today! Be sure to mention Discount Code C1001BLOG to save 15% off the standard registration rate.

posted in ExL Events News

live chat software